Liu Luyu, Zhou Jian, Song Xinran, Luo Guowei, Peng Min, Zhang Xiangyang
Department of Psychiatry, Shenzhen Nanshan People's Hospital, No 89, Taoyuan Road, Nanshan District, Shenzhen, 518052, PR China.
CAS Key Laboratory of Mental Health, Institute of Psychology, Chinese Academy of Sciences, 16 Lincui Road, Chaoyang District, Beijing, 100101, PR China.
BMC Psychiatry. 2024 Dec 4;24(1):880. doi: 10.1186/s12888-024-06332-8.
Thyroid dysfunction is commonly seen in major depressive disorder (MDD), and is particularly prevalent in female patients. Moreover, gender differences occur in many aspects of MDD, including suicide attempts (SAs). We aimed to explore gender differences in the prevalence and clinical correlates of SAs in young first-episode drug-naïve MDD patients with thyroid dysfunction, which have not yet been reported. We recruited 509 patients in this study. Demographic and clinical characteristics were collected. We used HAMD-17, HAMA-14, the positive subscale of PANSS, and CGI-S to assess every participant. We found no significant difference in the prevalence of SAs between male and female subgroup. Gender differences in factors associated with SAs were found with anxiety, body mass index, serum anti-thyroid antibodies (A-TPO), and free triiodothyronine levels in male patients and anxiety, CGI-S score, and A-TPO in female patients. We found no gender differences in the prevalence of SAs; however, there were gender differences in several clinical correlates of SAs, highlighting specific strategies to avoid SAs in male and female MDD patients.
甲状腺功能障碍在重度抑郁症(MDD)中很常见,在女性患者中尤为普遍。此外,MDD的许多方面都存在性别差异,包括自杀未遂(SA)。我们旨在探讨甲状腺功能障碍的年轻首发未用药MDD患者中SA患病率及临床相关因素的性别差异,此前尚未有相关报道。本研究招募了509名患者。收集了人口统计学和临床特征。我们使用汉密尔顿抑郁量表-17(HAMD-17)、汉密尔顿焦虑量表-14(HAMA-14)、阳性和阴性症状量表(PANSS)的阳性分量表以及临床总体印象量表-严重程度(CGI-S)对每位参与者进行评估。我们发现男性和女性亚组之间SA的患病率没有显著差异。在与SA相关的因素中发现了性别差异,男性患者的焦虑、体重指数、血清抗甲状腺抗体(A-TPO)和游离三碘甲状腺原氨酸水平,以及女性患者的焦虑、CGI-S评分和A-TPO。我们发现SA的患病率没有性别差异;然而,SA的几个临床相关因素存在性别差异,这突出了避免男性和女性MDD患者SA的特定策略。